CBSCBS News·1hHealth
score-0.50
FDA Updates GLP-1 Drug Labels to Note Potential Vision Loss Risk
Original
GLP-1s must now include warning for potential increased risk of vision loss, FDA announces
“Headline highlights a new safety warning regarding a serious medical side effect, creating a tone of caution and potential risk.”